This inhibitor proved to have a high specificity in the inhibition of STEP61 compared to other phosphatases; besides, no toxicity phenomena were observed in neuronal cultures, and it is capable of reversing the cognitive deficit in the AD mice model without affecting the classical markers of the disease (Tau phosphorylation and β-amyloid deposits) [29]. This evidence concerns the gene MAPT and Alzheimer disease.